Mateen A. Khan

About

Dr. Mateen A. Khan obtained his PhD degree (2002) in the field of Biotechnology from the Aligarh Muslim University, India, and later completed a postdoctoral fellowship in the Department of Biochemistry and Chemistry, Hunter College of the City University of New York, and School of Medicine, Stanford University, California, USA. Dr. Khan has published over 40 journal articles, review article, book and book chapter, and has been invited/attended over 40 national and international conferences. Dr. Khan is an active and productive member of the scientific community, serving as a reviewer for multiple scholarly journals. He is the recipient of Faculty Award for Research Excellence in 2022 and 2019 , and Faculty Excellence in Teaching in 2022 by the Alfaisal University. He has been identified as one of the best young scientist at the City University of New York by Gene Centre foundation and his name has been published by News Review. Dr. Khan's research achievements have been identified by the faculty of 1000 biology scientist. Dr. Khan is the recipient of several internal and external research grants. He has supervised or mentored several undergraduate and graduate students, and has served on multiples committees. Dr. Khan research interests are directed toward understanding the mechanism of gene regulation of iron mis-regulation in brain and neurodegenerative diseases (Alzheimer's and Parkinson's disease).

Research Interests:
Brain iron homeostasis; iron; iron dysregulation and neurodegenerative disease; 5’-untranslated regions; iron responsive elements (IREs) mRNA; Alzheimer’s disease, amyloid precursor protein; amyloid-beta precursor protein; Parkinson’s disease; alpha-synuclein; design RNA based peptide inhibitor; protein biosynthesis. Molecular Biophysics, Biochemistry, Molecular docking and MD simulation, Biophysical Characterization of RNA-protein and protein-protein interaction.

Employment

Employment history is unavailable.

Education

• A. M. University MSc
  1994 - 1996
• A.M.University BSc
  1990 - 1993

Projects & Funding

• Targeting amyloid precursor protein (APP) mRNA into novel therapeutics to control amyloid accumulation in Alzheimer’s disease Office of research and innovation, Alfaisal university
  2025 - 2027
• non-coding RNAs in cancer progression Alfaisal University
  2022 - 2023
• targeting the iron responsive element (IRE) mRNAs for the iron mis-regulation and diseases: role of translation initiation factor eIF4F Alfaisal University
  2020 - 2022
• Sequencing local SARS-CoV-2 isolates and developing multiplexing assay for diagnosis and genotyping Alfaisal University
  2020 - 2022
• Epigenetic dysregulation in breast cancer and their therapeutic implications Alfaisal University
  2019 - 2021
• Mechanism of activator eIF4F binding to iron responsive element (IRE) mRNA: A step towards developing new methods for therapeutic intervention in iron related diseases Alfaisal University
  2018 - 2020
• Mechanism of activator eIF4F binding to iron responsive element (IRE) mRNA: A step towards developing new methods for therapeutic intervention in iron related diseases Alfaisal University
  2018 - 2020
• Insight molecular mechanism in the maintenance of cellular iron homeostasis by iron regulatory proteins: A step towards therapeutic drug design for iron related diseases Alfaisal University
  2016 - 2018
• ASBMB Travel Award American Society for Biochemistry and Molecular Biology
  2010 - Present
• ASBMB American Society for Biochemistry and Molecular Biology
  2009 - Present
• ASBMB American Society for Biochemistry and Molecular Biology
  2008 - Present
• NIH Postdoctoral Research grant Gene Center Foundation CUNY
  2006 - 2008
• American Society of Biochemistry and Molecular Biology American Society for Biochemistry and Molecular Biology
  2006 - Present
• NIH Travel Award for Attending Biophysical Society meeting Biophysical Society
  2004 - Present

Publications

Publications are unavailable.